DescriptionRegeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.
Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.
Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.
A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.
What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.
Latest Press Releases
|Period||Period Low||Period High||Performance|
|1-Month|| 467.00 +15.74% increase |
| 554.84 -2.58% decrease |
| +51.58 (+10.55%) increase |
|3-Month|| 467.00 +15.74% increase |
| 596.80 -9.43% decrease |
| -39.30 (-6.78%) decrease |
|52-Week|| 328.13 +64.73% increase |
| 664.64 -18.68% decrease |
| +195.23 (+56.54%) increase |